Transforming Cancer Treatment with Innovative Solutions
At Oncogen Pharma, we are proud to offer a diverse and innovative product portfolio focused on addressing the critical needs of cancer patients. Our commitment to excellence drives us to develop high-quality oncology generics that make a real difference in the lives of those fighting cancer. Explore our range of products below:
NILOSIGNA is an oncology drug specifically designed for patients newly diagnosed with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in the chronic phase. With its targeted approach, NILOSIGNA aims to bring hope and transformation to patients by effectively managing their condition and improving their quality of life.
NILOSIGNA is an oncology drug specifically designed for patients newly diagnosed with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in the chronic phase. With its targeted approach, NILOSIGNA aims to bring hope and transformation to patients by effectively managing their condition and improving their quality of life.
The recommended dosage for Oncogen's medications may vary based on the specific treatment plan prescribed by your healthcare provider. Please follow your healthcare professional's instructions and the dosage information provided with your medication.
We understand the importance of safe and effective medication use in cancer treatment. Click on the “Safety Information” button below to learn more about the safety information.
We understand the importance of safe and effective medication use in cancer treatment. Click on the “Safety Information” button below to learn more about the safety information.
